ITPR2 Protein

ITPR2 Protein — Inositol 1,4,5-Trisphosphate Receptor Type 2

Introduction

Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2), also known as IP3 receptor subtype 2, is a ligand-gated calcium release channel located in the endoplasmic reticulum (ER) membrane that mediates the release of calcium ions into the cytoplasm in response to second messenger signaling. [@furuichi1993] ITPR2 belongs to the IP3 receptor family, a group of large tetrameric channels (approximately 270 kDa per subunit) that form calcium release channels in the ER membrane. Each functional channel consists of four subunits, each containing six transmembrane domains and a large cytoplasmic regulatory domain that binds inositol 1,4,5-trisphosphate (IP3), the second messenger generated by phospholipase C activation. [@bezprozvanny1991]

Calcium release through ITPR2 is a fundamental signaling mechanism in virtually all cell types, regulating synaptic plasticity, neuronal excitability, gene expression, and countless other calcium-dependent processes. [@mikoshiba1995] Dysregulation of ITPR2-mediated calcium signaling has been implicated in Alzheimer's disease, Parkinson's disease, Huntington's disease, and various cancers where calcium signaling pathways are often dysregulated. [@stutzmann2007][@bhattacharya2018]

ITPR2 Protein — Inositol 1,4,5-Trisphosphate Receptor Type 2

Introduction

Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2), also known as IP3 receptor subtype 2, is a ligand-gated calcium release channel located in the endoplasmic reticulum (ER) membrane that mediates the release of calcium ions into the cytoplasm in response to second messenger signaling. [@furuichi1993] ITPR2 belongs to the IP3 receptor family, a group of large tetrameric channels (approximately 270 kDa per subunit) that form calcium release channels in the ER membrane. Each functional channel consists of four subunits, each containing six transmembrane domains and a large cytoplasmic regulatory domain that binds inositol 1,4,5-trisphosphate (IP3), the second messenger generated by phospholipase C activation. [@bezprozvanny1991]

Calcium release through ITPR2 is a fundamental signaling mechanism in virtually all cell types, regulating synaptic plasticity, neuronal excitability, gene expression, and countless other calcium-dependent processes. [@mikoshiba1995] Dysregulation of ITPR2-mediated calcium signaling has been implicated in Alzheimer's disease, Parkinson's disease, Huntington's disease, and various cancers where calcium signaling pathways are often dysregulated. [@stutzmann2007][@bhattacharya2018]

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ITPR2 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Inositol 1,4,5-Trisphosphate Receptor Type 2</td></tr>
<tr><td><strong>Gene</strong></td><td>[ITPR2](/genes/itpr2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q14571](https://www.uniprot.org/uniprot/Q14571)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~270 kDa per subunit</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic Reticulum</td></tr>
<tr><td><strong>Protein Family</strong></td><td>IP3 receptor family (ITPR1, ITPR2, ITPR3)</td></tr>
<tr><td><strong>Tissue Distribution</strong></td><td>High in brain (cerebellum, hippocampus), pancreas, lung</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">PARKINSON</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">16 edges</a></td>
</tr>
</table>
</div>

Structure

Domain Architecture

ITPR2 has a characteristic IP3 receptor structure:

• N-terminal ligand-binding domain: The large cytoplasmic domain (approximately 2000 residues) that binds IP3 with high affinity. This domain contains the "IP3-binding core" and is the target for regulatory proteins.
• Modulatory domain: Located between the binding domain and the transmembrane region, this region contains binding sites for various regulatory proteins including calmodulin and FKBP12.
• Transmembrane domain: Six hydrophobic segments (M1-M6) that form the ion channel pore. The M1-M4 segments form the voltage sensor-like domain, while M5 and M6 along with the pore loop between them form the channel pore.
• C-terminal channel domain: Contains the channel pore and regulatory elements including the Ca²⁺ binding site that modulates channel activity.

Channel Properties

ITPR2 forms a tetrameric channel with the following properties:

• Conductance: Approximately 1 pS under physiological conditions
• Ion selectivity: Permeable to Ca²⁺, K⁺, and other small cations
• Gating: Regulated by IP3 binding, Ca²⁺ concentration, and numerous protein interactions
• Bell-shaped Ca²⁺ response: Low Ca²⁺ activates, high Ca²⁺ inhibits channel activity [@bezprozvanny1991]

Post-Translational Modifications

ITPR2 undergoes several important post-translational modifications:

• Phosphorylation: Phosphorylated by protein kinases A, C, and CaMKII
• Glycosylation: N-linked glycosylation in the transmembrane domains
• Sumoylation: Involved in regulating channel function and trafficking

Normal Physiological Functions

Calcium-Induced Calcium Release

ITPR2 mediates calcium-induced calcium release (CICR), a fundamental signaling mechanism where initial Ca²⁺ release triggers further release, amplifying the calcium signal. This process is crucial in:

• Neuronal excitability: Regulation of action potential firing patterns
• Synaptic plasticity: Long-term potentiation and depression
• Gene transcription: Calcium-dependent transcriptional activation

Synaptic Plasticity

In neurons, ITPR2 plays a critical role in synaptic plasticity:

• LTP induction: Ca²⁺ release through ITPR2 contributes to LTP in hippocampal neurons
• LTD induction: Store-operated calcium entry modulates LTD
• Dendritic spine morphology: Ca²⁺ signaling regulates spine shape and density

Neuronal Excitability

ITPR2 contributes to neuronal excitability through:

• Afterhyperpolarization: Regulates the post-spike hyperpolarization
• Burst firing: Modulates oscillatory activity in specific neuronal populations
• Integration of synaptic inputs: Ca²⁺ signals integrate multiple synaptic inputs

Gene Expression Regulation

Ca²⁺ release through ITPR2 activates:

• Calmodulin-dependent kinases: CaMKIV activation
• Transcription factors: CREB phosphorylation and activation
• Nuclear import: Calmodulin nuclear translocation

Cellular Homeostasis

ITPR2 participates in cellular calcium homeostasis:

• ER calcium store management: Controls ER calcium release
• Store-operated calcium entry: Triggers plasma membrane calcium channels
• Mitochondrial calcium uptake: Links ER release to mitochondrial function

Role in Neurodegenerative Diseases

Alzheimer's Disease

ITPR2 dysfunction is strongly implicated in Alzheimer's disease pathogenesis:

Calcium Dysregulation Hypothesis

The "calcium dysregulation hypothesis" of AD proposes that altered calcium signaling is an early event in disease progression. [@stutzmann2007] ITPR2 contributes to this through:

Amyloid-Beta Effects

Amyloid-beta oligomers directly interact with ITPR2:

• Increased Ca²⁺ release through ITPR2
• Enhanced channel open probability
• Disrupted Ca²⁺ homeostasis in hippocampal neurons [@del Prete2014]

Tau Pathology

Tau pathology affects ITPR2 function:

• Altered subcellular distribution of ITPR2
• Enhanced channel activity in tau-bearing neurons
• Contributes to synaptic dysfunction [@bhattacharya2018]

Therapeutic Implications

Restoring ITPR2 function is a promising therapeutic strategy:

• Gene therapy: AAV-mediated ITPR2 modulation
• Small molecule modulators: Targeting specific channel subtypes
• Store-operated calcium entry enhancers: Compensating for dysregulated release [@popugaeva2017]

Parkinson's Disease

ITPR2 alterations contribute to dopaminergic neuron degeneration:

Mitochondrial Dysfunction

ITPR2-mediated Ca²⁺ release links to mitochondrial dysfunction:

• Altered mitochondrial calcium uptake
• Enhanced mitochondrial permeability transition
• Increased oxidative stress [@linde2018]

Alpha-Synuclein Interactions

Alpha-synuclein affects ITPR2 function:

• Direct binding to ITPR2 alters channel activity
• Enhanced Ca²⁺ release in neurons with Lewy bodies
• Contributes to excitotoxicity

Therapeutic Targeting

ITPR2 modulators may benefit PD:

• Reducing excessive Ca²⁺ release
• Protecting dopaminergic neurons
• Improving mitochondrial function [@selvaraj2019]

Huntington's Disease

ITPR2 is profoundly affected in Huntington's disease:

Striatal Signaling

ITPR2 alterations in striatal neurons:

• Enhanced channel activity
• Altered GABAergic signaling
• Contributing to motor symptoms

Mutant Huntingtin Effects

Mutant huntingtin protein affects ITPR2:

• Altered channel trafficking
• Enhanced Ca²⁺ release
• Contributes to excitotoxicity

Other Neurodegenerative Conditions

ITPR2 dysfunction is implicated in:

• Amyotrophic lateral sclerosis (ALS): Altered calcium homeostasis in motor neurons
• Frontotemporal dementia: Synaptic calcium dysregulation
• Epilepsy: Enhanced neuronal excitability

Expression Pattern

ITPR2 shows tissue-specific expression:

Brain Regions

• Cerebellum: Highest expression in Purkinje cells
• Hippocampus: CA1-CA3 regions, dentate gyrus
• Cortex: Layer-specific expression in pyramidal neurons
• Striatum: Medium spiny neurons
• Substantia nigra: Dopaminergic neurons

Other Tissues

• Pancreas: Islet cells
• Lung: Alveolar epithelial cells
• Heart: Cardiac myocytes
• Immune cells: Lymphocytes, macrophages

Molecular Interactions

ITPR2 interacts with numerous proteins:

| Protein | Interaction | Functional Effect |
|---------|-------------|-------------------|
| Homer | Scaffold | Anchors ITPR to postsynaptic density |
| RyR | Calcium release | Coordinates calcium signaling |
| Calmodulin | Calcium sensing | Modulates channel activity |
| FKBP12 | Immunophilin | Regulates gating |
| BAP31 | ER chaperone | Involved in trafficking |
| mGluR1/5 | GPCR signaling | Couples to IP3 production |

Animal Models

Knockout Studies

• Itpr2⁻/⁻ mice: Viable with subtle neurological phenotypes
• Conditional knockouts: Brain-specific deletion
• Phenotypes: Altered synaptic plasticity, behavior changes

Transgenic Models

• ITPR2 overexpression: Enhanced calcium release
• Mutant ITPR2: Modeling disease-linked variants
• AD model crosses: ITPR2 × APP/PS1 mice

Therapeutic Strategies

Modulators

| Compound | Target | Development Stage |
|----------|--------|-------------------|
| Xestospongin C | ITPR antagonist | Research |
| 2-APB | ITPR modulator | Research |
| Caffeine | RyR/ITPR activator | Clinical use |

Gene Therapy

• AAV-mediated ITPR2 delivery
• RNAi-based knockdowns
• CRISPR-based editing

Combination Approaches

• ITPR modulators + antioxidants
• Calcium channel blockers + ITPR targeting
• Neuroprotective strategies

Research Directions

Current research focuses on:

• Subtype-specific targeting: Developing ITPR2-selective modulators
• Structural studies: Cryo-EM of ITPR2 in various states
• Biomarker development: ITPR2 as disease biomarker
• Clinical trials: Testing calcium modulators in neurodegenerative diseases

Key Publications

See Also

• [ITPR2 Gene](/genes/itpr2)
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Calcium Signaling Dysregulation](/mechanisms/calcium-signaling-dysregulation)
• [ER Stress](/mechanisms/er-stress-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [UniProt: Q14571](https://www.uniprot.org/uniprot/Q14571)
• [NCBI Gene: ITPR2](https://www.ncbi.nlm.nih.gov/gene/3709)
• [IUPHAR: ITPR2](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=379)
• [PDB: ITPR Structures](https://www.rcsb.org/)
• [OMIM: ITPR2](https://www.omim.org/entry/3709)

References